NCT04249323View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

October 15, 2020

Study Completion Date

October 15, 2020

Conditions
Healthy Adults
Interventions
DRUG

CORT113176 Lipid Capsule Formulation

CORT113176 Lipid Capsule Formulation 10-200 mg for oral administration

DRUG

Placebo matching CORT113176 Lipid Capsule Formulation

Placebo matching CORT113176 Lipid Capsule Formulation 10-200 mg for oral administration

DRUG

Prednisone

Prednisone standard release tablets 1 x 20 mg plus 1 x 5 mg for oral administration

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY